Investor

Investor

News Release

<< Back 
Memory Pharmaceuticals to Present at Upcoming Investor Conferences

MONTVALE, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that James Sulat, President and Chief Executive Officer, will be presenting at the following upcoming investor conferences:

Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Monday, November 5, 2007 at 10:15 a.m. Eastern Time at The New York Palace Hotel in New York City.

CIBC World Markets 18th Annual Healthcare Conference on Tuesday, November 6, 2007 at 2:30 p.m. Eastern Time at the Waldorf-Astoria Hotel in New York City.

JMP Securities Sector Focus Conference on Tuesday, November 13, 2007 at 9:30 a.m. Eastern Time at the Four Seasons Hotel in Boston, MA.

Lazard Capital Markets Fourth Annual Healthcare Conference on Tuesday, November 27, 2007 at 4.00 p.m. Eastern Time at The New York Palace Hotel in New York City.

Interested parties may access a live audio webcast of the presentations by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com. Archived versions of the webcasts will be available at the same location for one week following each of the presentations.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.

SOURCE  Memory Pharmaceuticals Corp.
    -0-                             10/29/2007
    /CONTACT:  Jzaneen Lalani, General Counsel, +1-201-802-7249; or Laura
Perry of Stern Investor Relations, Inc., +1-212-362-1200, both for Memory
Pharmaceuticals Corp./
    /Web site:  http://www.memorypharma.com /
    (MEMY)

CO:  Memory Pharmaceuticals Corp.
ST:  New Jersey, New York
IN:  BIO MTC HEA
SU:  TDS

SS-AL
-- NYM132 --
8389 10/29/2007 14:07 EDT http://www.prnewswire.com